Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphoma.
Clement BaillyThomas CarlierBenoit TessoulinThomas GastinneFrançoise Kraeber-BodereSteven Le GouillCaroline Bodet-MilinPublished in: Hematological oncology (2022)